AbbVie Inc.

Q1 2026 View transcript ↗ Q4 2025 View transcript ↗ Q3 2025 View transcript ↗ Q2 2025 View transcript ↗

Robert A. Michael — Chairman of the Board and Chief Executive Officer View full profile ↗ Roxanne S. Austin — Lead Independent Director; President, Austin Investment Advisors View full profile ↗ William H.L. Burnside — Retired Senior Vice President and Director, The Boston Consulting Group View full profile ↗ Jennifer L. Davis — Chief Executive Officer, Health Care, Procter & Gamble View full profile ↗ Thomas J. Falk — Retired Chairman and Chief Executive Officer, Kimberly-Clark Corporation View full profile ↗ Thomas C. Freyman — Retired Executive Vice President, Finance and Administration, Abbott Laboratories View full profile ↗ Brett J. Hart — President, United Airlines Holdings, Inc. View full profile ↗ Melody B. Meyer — Retired President, Chevron Asia Pacific Exploration and Production View full profile ↗ Susan E. Quaggin, M.D. — Chair of Medicine, Northwestern University Feinberg School of Medicine View full profile ↗ Edward J. Rapp — Retired Group President, Caterpillar Inc. View full profile ↗ Rebecca B. Roberts — Retired President, Chevron Pipe Line Company View full profile ↗ Frederick H. Waddell — Retired Chairman and Chief Executive Officer, Northern Trust Corporation View full profile ↗ Robert J. Alpern, M.D. — Ensign Professor of Medicine and Physiology and Former Dean of Yale School of Medicine View full profile ↗ Scott T. Reents — Executive Vice President, Chief Financial Officer View full profile ↗ Demetris D. Crum — Executive Vice President, Chief Human Resources Officer View full profile ↗ Nicholas J. Donoghoe, M.D. — Executive Vice President, Chief Business and Strategy Officer View full profile ↗ Azita Saleki-Gerhardt, Ph.D. — Executive Vice President, Chief Operations Officer View full profile ↗ Perry C. Siatis — Executive Vice President, General Counsel and Secretary View full profile ↗ Jeffrey R. Stewart — Executive Vice President, Chief Commercial Officer View full profile ↗ Roopal Thakkar, M.D. — Executive Vice President, Research & Development and Chief Scientific Officer View full profile ↗ David R. Purdue — Senior Vice President, Controller View full profile ↗

AbbVie acquires Allergan plc — Medical aesthetics, neuroscience, eye care & immunology · 2020 View full deal ↗ AbbVie acquires Pharmacyclics, Inc. — Hematologic oncology · 2015 View full deal ↗ AbbVie acquires ImmunoGen, Inc. — Oncology (solid tumors / ADCs) · 2024 View full deal ↗ AbbVie acquires Cerevel Therapeutics Holdings, Inc. — Neuroscience · 2024 View full deal ↗ AbbVie acquires Stemcentrx, Inc. — Oncology (solid tumors) · 2016 View full deal ↗ AbbVie acquires Capstan Therapeutics, Inc. — In vivo cell engineering / immunology · 2025 View full deal ↗ AbbVie acquires Aliada Therapeutics Holdings, Inc. — Neuroscience (CNS) · 2024 View full deal ↗ AbbVie acquires Gilgamesh Pharmaceuticals, Inc. — Neuroscience (psychiatry) · 2025 View full deal ↗ AbbVie acquires Nimble Therapeutics, Inc. — Immunology · 2025 View full deal ↗ AbbVie acquires Celsius Therapeutics, Inc. — Immunology (IBD) · 2024 View full deal ↗ AbbVie acquires Syndesi Therapeutics SA — Neuroscience · 2022 View full deal ↗ AbbVie acquires Landos Biopharma, Inc. — Immunology (IBD) · 2024 View full deal ↗